AN INDIVIDUALISED DECISION MAKING TOOL FOR USE OF LOW VERSUS STANDARD DOSE ALTEPLASE IN ACUTE ISCHAEMIC STROKE

被引：0
|
作者：
Wang, X. [1 ]
Anderson, C. [2 ]
Moullaali, T. [2 ]
Woodward, M. [3 ]
机构：
[1] NMH, George Inst Global Hlth, Sydney, NSW, Australia
[2] George Inst Global Hlth, Neurol & Mental Hlth, Sydney, NSW, Australia
[3] George Inst Global Hlth, Profess Unit, Sydney, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF STROKE | 2018年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
046
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [31] Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
    Sandercock, Peter A. G.
    Leong, Tze Shin
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (04):
  • [32] Pharmacological management of acute ischaemic stroke involves thrombolysis with alteplase and the use of a number of supportive interventions
    不详
    Drugs & Therapy Perspectives, 2013, 29 (8) : 236 - 240
  • [33] A decision analysis of thrombolytic therapy compared with standard therapy in acute ischaemic stroke
    Hallan, S
    Åsberg, A
    Indredavik, B
    Wideroe, TE
    JOURNAL OF INTERNAL MEDICINE, 1999, 246 (06) : 549 - 559
  • [34] IS LOW DOSE ALTEPLASE A VIABLE OPTION FOR ACUTE ISCHEMIC STROKE IN DEVELOPING COUNTRIES
    Goswami, A.
    Renjen, P.
    Jindal, K.
    Chaudhari, D.
    Jain, S.
    Pandey, S.
    INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (3_SUPPL) : 150 - 150
  • [35] Low-Dose versus Standard-Dose Alteplase in Bridging Therapy for Large Vessel Stroke: A Systematic Review and Meta-Analysis
    Yang, Ta-Wei
    Lee, Ya-Han
    Lo, Wei-Cheng
    Chen, I-Ting
    Lin, Han-Chun
    Chen, Ming-Hua
    Lee, Chiao-Hua
    Hsu, Yuan-Pin
    Tam, Ka-Wai
    CEREBROVASCULAR DISEASES, 2025, 53 (06) : 657 - 666
  • [36] Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial
    Chen, Guofang
    Wang, Xia
    Robinson, Thompson G.
    Pikkemaat, Miriam
    Lindley, Richard I.
    Zhou, Shengkui
    Ping, Lei
    Liu, Weiwei
    Liu, Leijing
    Chalmers, John
    Anderson, Craig S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 387 : 1 - 5
  • [37] Tenecteplase versus alteplase for acute ischaemic stroke: a meta-analysis of phase III randomised trials
    Xiong, Yunyun
    Wang, Liyuan
    Li, Guangshuo
    Yang, Kai-Xuan
    Hao, Manjun
    Li, Shuya
    Pan, Yuesong
    Wang, Yongjun
    STROKE AND VASCULAR NEUROLOGY, 2024, 9 (04) : 360 - 366
  • [38] Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke
    Fiehler, Jens
    Nawka, Marie Teresa
    Meyer, Lukas
    CURRENT OPINION IN NEUROLOGY, 2022, 35 (01) : 18 - 23
  • [39] Low-Dose vs Standard-Dose Alteplase for Patients With Acute Ischemic Stroke Secondary Analysis of the ENCHANTED Randomized Clinical Trial
    Wang, Xia
    Robinson, Thompson G.
    Lee, Tsong-Hai
    Li, Qiang
    Arima, Hisatomi
    Bath, Philip M.
    Billot, Laurent
    Broderick, Joseph
    Demchuk, Andrew M.
    Donnan, Geoffrey
    Kim, Jong S.
    Lavados, Pablo
    Lindley, Richard I.
    Martins, Sheila O.
    Olavarria, Veronica V.
    Pandian, Jeyaraj D.
    Parsons, Mark W.
    Pontes-Neto, Octavio M.
    Ricci, Stefano
    Sharma, Vijay K.
    Thang, Nguyen H.
    Wang, Ji-Guang
    Woodward, Mark
    Anderson, Craig S.
    Chalmers, John
    JAMA NEUROLOGY, 2017, 74 (11) : 1328 - 1335
  • [40] Effectiveness of Standard-Dose vs. Low-Dose Alteplase for Acute Ischemic Stroke Within 3-4.5 h
    Chen, Chih-Hao
    Tang, Sung-Chun
    Chen, Yu-Wei
    Chen, Chih-Hung
    Tsai, Li-Kai
    Sung, Sheng-Feng
    Lin, Huey-Juan
    Huang, Hung-Yu
    Po, Helen L.
    Sun, Yu
    Chen, Po-Lin
    Chan, Lung
    Wei, Cheng-Yu
    Lee, Jiunn-Tay
    Hsieh, Cheng-Yang
    Lin, Yung-Yang
    Lien, Li-Ming
    Jeng, Jiann-Shing
    FRONTIERS IN NEUROLOGY, 2022, 13
12345